ITVR940096A0 - Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. - Google Patents

Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Info

Publication number
ITVR940096A0
ITVR940096A0 ITVR940096A ITVR940096A ITVR940096A0 IT VR940096 A0 ITVR940096 A0 IT VR940096A0 IT VR940096 A ITVR940096 A IT VR940096A IT VR940096 A ITVR940096 A IT VR940096A IT VR940096 A0 ITVR940096 A0 IT VR940096A0
Authority
IT
Italy
Prior art keywords
immunadorption
antigen
complex
procedure
equipment
Prior art date
Application number
ITVR940096A
Other languages
English (en)
Inventor
Alessandro Zuccato
Original Assignee
Sanitaria Scaligera Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanitaria Scaligera Spa filed Critical Sanitaria Scaligera Spa
Publication of ITVR940096A0 publication Critical patent/ITVR940096A0/it
Priority to ITVR940096A priority Critical patent/IT1271593B/it
Priority to AU41864/96A priority patent/AU4186496A/en
Priority to AT95940399T priority patent/ATE242637T1/de
Priority to JP08518558A priority patent/JP2000516193A/ja
Priority to DE69531069T priority patent/DE69531069T2/de
Priority to ES95940399T priority patent/ES2201125T3/es
Priority to PCT/IT1995/000206 priority patent/WO1996016666A1/en
Priority to EP95940399A priority patent/EP0954325B1/en
Publication of ITVR940096A1 publication Critical patent/ITVR940096A1/it
Application granted granted Critical
Publication of IT1271593B publication Critical patent/IT1271593B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITVR940096A 1994-11-30 1994-11-30 Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. IT1271593B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITVR940096A IT1271593B (it) 1994-11-30 1994-11-30 Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
DE69531069T DE69531069T2 (de) 1994-11-30 1995-11-30 Verfahren zur spezifischen immunabsorption von selektierten pathogenen faktoren zur behandlung von aids
AT95940399T ATE242637T1 (de) 1994-11-30 1995-11-30 Verfahren zur spezifischen immunabsorption von selektierten pathogenen faktoren zur behandlung von aids
JP08518558A JP2000516193A (ja) 1994-11-30 1995-11-30 エイズ（ａｉｄｓ）の治療において選択された病原性因子類を特異的に免疫吸着するためのモジュール
AU41864/96A AU4186496A (en) 1994-11-30 1995-11-30 Method for the specific immunoadsorption of selected pathogenic factors
ES95940399T ES2201125T3 (es) 1994-11-30 1995-11-30 Metodo para inmunoadsorcion especifica de factores patogenos seleccionados para el tratamiento del sida.
PCT/IT1995/000206 WO1996016666A1 (en) 1994-11-30 1995-11-30 Method for the specific immunoadsorption of selected pathogenic factors
EP95940399A EP0954325B1 (en) 1994-11-30 1995-11-30 Method for the specific immunoadsorption of selected pathogenic factors in the treatment of aids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITVR940096A IT1271593B (it) 1994-11-30 1994-11-30 Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Publications (3)

Publication Number Publication Date
ITVR940096A0 true ITVR940096A0 (it) 1994-11-30
ITVR940096A1 ITVR940096A1 (it) 1996-05-30
IT1271593B IT1271593B (it) 1997-06-04

Family

ID=11427924

Family Applications (1)

Application Number Title Priority Date Filing Date
ITVR940096A IT1271593B (it) 1994-11-30 1994-11-30 Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Country Status (8)

Country Link
EP (1) EP0954325B1 (it)
JP (1) JP2000516193A (it)
AT (1) ATE242637T1 (it)
AU (1) AU4186496A (it)
DE (1) DE69531069T2 (it)
ES (1) ES2201125T3 (it)
IT (1) IT1271593B (it)
WO (1) WO1996016666A1 (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998002174A1 (de) * 1996-07-12 1998-01-22 Imtec Immundiagnostika Gmbh Selektives adsorbens zur bindung von retroviren
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
ATE488251T1 (de) 2004-09-24 2010-12-15 Beth Israel Hospital Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
US20060153835A1 (en) * 2005-01-12 2006-07-13 Smith Henry J Treatment of pre-eclampsia in pregnant women using targeted apheresis
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
US9241977B2 (en) 2013-03-01 2016-01-26 Arthrex, Inc. Enhanced anabolic cytokine production and delivery system
SG11201604881TA (en) * 2013-12-27 2016-08-30 Eliaz Therapeutics Inc Plasmapheresis device
DE102016106510A1 (de) * 2016-04-08 2017-10-12 ToposNomos Ltd. Verfahren und Vorrichtung zum extrakorporalen Entfernen von pathogenen und/oder überzähligen Bestandteilen aus einer Zellprobe eines Patienten
CN106267416B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病治疗仪
CN106267414B (zh) * 2016-07-01 2019-02-19 翁炳焕 艾滋病免疫净化器
FR3109734B1 (fr) * 2020-05-04 2025-04-11 Univ Claude Bernard Lyon Système de dialyse pour le traitement du sepsis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1536425A (en) * 1976-01-30 1978-12-20 Nat Res Dev Blood treatment
WO1980002805A1 (en) * 1979-06-11 1980-12-24 Gambro Ab Process for the treating of and/or removal of substances from a liquid,especially whole blood,and a device and a membrane for the realization of said process
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
DE3381105D1 (de) * 1982-08-12 1990-02-22 Kanegafuchi Chemical Ind Aktivierung biovertraeglicher terpolymere mit biologischen stoffen, deren anzubindende komplemente pathologische effektoren sind.
US5037649A (en) * 1985-01-11 1991-08-06 Imre Corporation Method for treatment of HIV-infected patients
EP0685236A1 (en) * 1987-06-10 1995-12-06 The Immune Response Corporation, Inc. Prevention and treatment of retroviral disease
US4831118A (en) * 1987-08-07 1989-05-16 Scripps Clinic And Research Foundation Flouroplastic immunoaffinity columns for purification of blood proteins
SK285624B6 (sk) * 1990-11-08 2007-05-03 Chiron Corporation Hepatitis C vírusový (HCV) skrátený asialoglykoproteín, kompozícia s jeho obsahom a jeho použitie
US5223397A (en) * 1991-06-05 1993-06-29 Sangstat Medical Corporation Soluble hla cross-match
DE4331358A1 (de) * 1992-10-12 1994-04-14 Braun Melsungen Ag Verfahren zur quantitativen selektiven Entfernung oder präparativen Gewinnung von Tumor-Nekrose-Faktor (TNF) oder/und Lipopolysacchariden (LPS) aus wäßrigen Flüssigkeiten
CA2140455A1 (en) * 1993-05-28 1994-12-08 William C. Lake Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations

Also Published As

Publication number Publication date
ES2201125T3 (es) 2004-03-16
ATE242637T1 (de) 2003-06-15
WO1996016666A1 (en) 1996-06-06
JP2000516193A (ja) 2000-12-05
ITVR940096A1 (it) 1996-05-30
EP0954325B1 (en) 2003-06-11
IT1271593B (it) 1997-06-04
AU4186496A (en) 1996-06-19
DE69531069D1 (de) 2003-07-17
DE69531069T2 (de) 2004-05-06
EP0954325A1 (en) 1999-11-10

Similar Documents

Publication Publication Date Title
EP0777497A4 (en) HUMAN MONOCLONAL ANTIBODIES NEUTRALIZING THE HUMAN IMMUNIDE DEFICIENCY VIRUS
NO905438D0 (no) Virusmiddel.
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
FI952302L (fi) Pyran-2-onit ja 5,6-dihydropyranonit, jotka ovat käyttökelpoisia HIV:n ja muiden retrovirusten hoidossa
EP0710667A3 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
ZA956797B (en) Method for preparing influenza virus, antigens obtained and the applications.
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
ATE82574T1 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
CA2192512A1 (en) Nm03 antibody materials and methods
ITVR940096A0 (it) Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
DE69005192D1 (de) Diffusionsverbinden und superplastisches Verformen.
NO892057D0 (no) Psylliumpreparat, samt fremgangsmaate for fremstilling av det.
ZA964679B (en) Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
AU7444891A (en) New hiv p24 peptides, diagnostic antigens and discriminative immunoassay method
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
IT1236969B (it) Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone.
FI955335A0 (fi) Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav foer anvaendning som kontrastmedel och foerfarande foer framstaellning av dessa
NO911543D0 (no) Katalysatorsystem og fremgangsmaate for fremstilling av 1,2-diklorethan.
FR2668539B1 (fr) Silencieux d'echappement.
IT8721945A0 (it) Procedimento per la profumazione di libri, dispositivo per l'attuazione di detto procedimento
ZA984100B (en) Process for the detection of HIV antibodies and antigens used in it.
ZA916313B (en) New use of a monoclonal antibody

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971130